These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32925013)

  • 1. The diagnostic performance of perfusion CT in the detection of local tumor recurrence in head and neck cancer.
    Troeltzsch D; Niehues SM; Fluegge T; Neckel N; Heiland M; Hamm B; Shnayien S
    Clin Hemorheol Microcirc; 2020; 76(2):171-177. PubMed ID: 32925013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of dynamic volume perfusion CT for differentiation of head and neck cancer from healthy tissue and post-therapeutic changes.
    Troeltzsch D; Shnayien S; Gaudin R; Bressem K; Kreutzer K; Heiland M; Hamm B; Niehues S
    Clin Hemorheol Microcirc; 2021; 78(1):93-101. PubMed ID: 33554889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion CT of head and neck cancer.
    Razek AA; Tawfik AM; Elsorogy LG; Soliman NY
    Eur J Radiol; 2014 Mar; 83(3):537-44. PubMed ID: 24387935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
    Kim ES; Yoon DY; Moon JY; Baek S; Han YM; Seo YL; Yun EJ
    Acta Radiol; 2019 Feb; 60(2):186-195. PubMed ID: 29754496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Han EJ; O JH; Yoo IR; Kim YS; Kim MS; Kang JH; Choi WH
    Hell J Nucl Med; 2017; 20(2):134-140. PubMed ID: 28697190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
    Mehanna H; Kong A; Ahmed SK
    J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic efficacy of dynamic contrast-enhanced magnetic resonance perfusion imaging in detecting local tumor recurrence in patients with head and neck malignancies after definitive treatment.
    Lathika AG; Jayasankaran SC; Chelakkot PG; Thankappan K; Moorthy S
    J Cancer Res Ther; 2024 Apr; 20(3):793-801. PubMed ID: 39023585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Energy Perfusion-CT in Recurrent Pancreatic Cancer - Preliminary Results.
    Fritz F; Skornitzke S; Hackert T; Kauczor HU; Stiller W; Grenacher L; Klauss M
    Rofo; 2016 Jun; 188(6):559-65. PubMed ID: 27224576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT perfusion of the neck: internal carotid artery versus external carotid artery as the reference artery.
    Miracle AC; Rezaei A; Gandhi D; Mukherji SK
    AJNR Am J Neuroradiol; 2009 Sep; 30(8):1598-601. PubMed ID: 19369615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of 2-[18F]-fluoro-2-deoxy-D-glucose imaging with dual-head gamma camera in coincidence mode: comparison with computed tomography/magnetic resonance imaging in patients with suspected recurrent head and neck cancers.
    Gandhi D; Falen S; McCartney W; Shockley W; Weissler M; Wrenn S; Shah G; Mukherji SK
    J Comput Assist Tomogr; 2005; 29(4):513-9. PubMed ID: 16012310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI.
    Lell M; Baum U; Greess H; Nömayr A; Nkenke E; Koester M; Lenz M; Bautz W
    Eur J Radiol; 2000 Mar; 33(3):239-47. PubMed ID: 10699740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
    Mohamed ASR; Cardenas CE; Garden AS; Awan MJ; Rock CD; Westergaard SA; Brandon Gunn G; Belal AM; El-Gowily AG; Lai SY; Rosenthal DI; Fuller CD; Aristophanous M
    Radiother Oncol; 2017 Aug; 124(2):248-255. PubMed ID: 28774596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
    Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
    Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
    Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion CT for head and neck tumors: pilot study.
    Rumboldt Z; Al-Okaili R; Deveikis JP
    AJNR Am J Neuroradiol; 2005 May; 26(5):1178-85. PubMed ID: 15891181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced CT and MR Imaging of the Posttreatment Head and Neck.
    Lobo R; Turk S; Bapuraj JR; Srinivasan A
    Neuroimaging Clin N Am; 2022 Feb; 32(1):133-144. PubMed ID: 34809834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
    Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.